You are here

  • Home
  • Archive
  • Volume 62, Issue Suppl 1
  • OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive)

Citation Tools

Article menu

Download PDFPDF

Liver symposium: impact of clinical research in hepatology
OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Basu P, Shah NJ, Farhat S, et al
OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive)
Gut 2013;62:A23.